Blueprint Medicines
BPMC
$108.31
Share price
-0.22%
Change (1 day)
98.01%
Change (1 year)
Categories
Operating Margin for Blueprint Medicines (BPMC)
Operating Margin as of May 2024 (TTM): -244.45%
According to Blueprint Medicines 's latest financial reports and stock price the company's current Operating Margin is -244.45%. At the end of 2022 the company had an Operating Margin of -263.44%.
Operating Margin history for Blueprint Medicines from 2015 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | -263.44% | -26.1% |
| 2021 | -356.50% | -1016.61% |
| 2020 | 38.89% | -107.16% |
| 2019 | -543.25% | 2.24% |
| 2018 | -531.36% | -23.02% |
| 2017 | -690.27% | 166.16% |
| 2016 | -259.35% | -43.22% |
| 2015 | -456.78% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Pacific Biosciences
PACB | -218.42% | -10.65% | 🇺🇸 USA |
 OPKO Health
OPK | -36.36% | -85.13% | 🇺🇸 USA |
 Acceleron Pharma XLRN | -226.57% | -7.31% | 🇺🇸 USA |
 Isoray
ISR | -67.36% | -72.44% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.